Long-term follow-up of Fanconi anemia: clinical manifestation and treatment outcome
Korean Journal of Pediatrics 2014³â 57±Ç 3È£ p.125 ~ p.134
À±º´±Ô(Yoon Byung-Gyu) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
±èÈñ³ª(Kim Hee-Na) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
(Han Ui-Joung) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
ÀåÇØÀÎ(Jang Hae-In) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
Çѵ¿±Õ(Han Dong-Kyun) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
¹éÈñÁ¶(Baek Hee-Jo) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
ȲÅÂÁÖ(Hwang Tai-Ju) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
±¹ÈÆ(Kook Hoon) - Chonnam National University Medical School Chonnam National University Hospital Department of Pediatrics
Abstract
Purpose: The aim of this study was to characterize Korean patients with Fanconi anemia (FA), which is a rare but very challenging genetic disease.
Methods: The medical records of 12 FA patients diagnosed at Chonnam National University Hospital from 1991 to 2012 were retrospectively reviewed.
Results:The median age at diagnosis was 6.2 years. All patients showed evidence of marrow failure and one or more physical stigmata. Chromosome breakage tests were positive in 9 out of 11 available patients. The median follow-up duration was 69.5 months. The Kaplan-Meier (K-M) survival of all patients was 83.3% at 10 years and 34.7% at 20 years, respectively. Seven patients underwent 9 stem cell transplantations (SCTs). Among them, 5 were alive by the end of the study. Ten-year K-M survival after SCT was 71.4% with a median follow-up of 3.4 years. All 5 patients treated with supportive treatment alone died of infection or progression at the median age of 13.5 years, except for one with short followup duration. Acute leukemia developed in 2 patients at 15.4 and 18.1 years of age. Among 6 patients who are still alive, 3 had short stature and 1 developed insulin-dependent diabetes mellitus.
Conclusion: We provide information on the long-term outcomes of FA patients in Korea. A nation-wide FA registry that includes information of the genotypes of Korean patients is required to further characterize ethnic differences and provide the best standard of care for FA patients.
Å°¿öµå
Fanconi anemia, Korean, Stem cell transplantation, Long-term outcome
KMID :
1130320140570030125
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)